Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China · Delayed Price · Currency is CNY 10.38
-0.15 (-1.42%)
Mar 19, 2026, 3:00 PM CST
SHA:600267 Market Cap
SHA:600267 has a market cap or net worth of 12.07 billion as of March 18, 2026. Its market cap has increased by 20.83% in one year.
Market Cap
12.07B
Enterprise Value
14.21B
Revenue
9.84B
Ranking
n/a
PE Ratio
21.87
Stock Price
10.38
Market Cap Chart
Since August 15, 2006, SHA:600267's market cap has increased from 2.44B to 12.07B, an increase of 395.81%. That is a compound annual growth rate of 8.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 12.25B | 6.47% |
| Dec 31, 2025 | 11.50B | 18.59% |
| Dec 31, 2024 | 9.70B | -12.87% |
| Dec 29, 2023 | 11.13B | -13.94% |
| Dec 30, 2022 | 12.94B | -22.69% |
| Dec 31, 2021 | 16.73B | 4.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Chipscreen Biosciences | 13.69B |
| Beijing Aosaikang Pharmaceutical | 13.63B |
| Zhejiang Jingxin Pharmaceutical | 13.27B |
| Henan Lingrui Pharmaceutical | 12.59B |
| Guangdong Taienkang Pharmaceutical | 11.63B |
| Porton Pharma Solutions | 11.41B |
| Zhejiang Hisoar Pharmaceutical | 11.29B |
| Mayinglong Pharmaceutical Group | 11.26B |